Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3,077.03 | 15.19 |
PEG Ratio (TTM) | 24.14 | 0.01 |
P/S Ratio (TTM) | 3.62 | 2.58 |
P/B Ratio (TTM) | 0.77 | 1.36 |
P/FCF Ratio (TTM) | -488.93 | 5.16 |
Price to 5YR AVG Earnings Ratio | 66.87 | 14.70 |
Price to 5YR AVG FCF Ratio | 90.80 | 8.90 |
Profitability (5%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.00% | 0.94% |
ROE (TTM) | -0.03% | 9.37% |
Net Profit Margin (TTM) | -0.11% | 16.40% |
ROIC 5YR AVG | 2.27% | 16.83% |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 258.66% | 28.67% | -6.44% |
Revenue | 3.39% | 18.98% | 7.25% |
Net Income | 228.26% | 44.01% | 0.83% |
Cash Flow | -25.21% | 536.41% | 303.93% |
Health (63%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 19.14 | 12.34 |
Quick Ratio (TTM) | 19.14 | 12.58 |
D/E Ratio (TTM) | 0.30 | 1.06 |
Interest Coverage (TTM) | -0.03 | 0.74 |
Piotroski F-Score | 6 | 6 |
Altman Z-Score | 0.52 | 0.44 |
LTL to 5YR AVG FCF | 7.03 | 5.11 |
Shares Outstanding Growth 5YR AVG | 40.15% | 34.81% |